Evidence map›Paper›PMID 11753646›Full record

ArticleOncogene2001

Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas.

W Chen, N Palanisamy, H Schmidt, J Teruya-Feldstein, S C Jhanwar, A D Zelenetz, J Houldsworth, R S Chaganti

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Fc gamma receptors and cancer.Springer seminars in immunopathology · 2006
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Inhibitory Fc gamma receptors: from gene to disease.Journal of clinical immunology · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

W ChenCell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
N Palanisamy
H Schmidt
J Teruya-Feldstein
S C Jhanwar
A D Zelenetz
J Houldsworth
R S Chaganti
Memorial Sloan Kettering Cancer Center · US

Funding

MAPPING CHROMOSOMES AND GENES RELATION TO LEUKEMIAR01CA034775 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI CHAGANTI, RAJU S.K. · 1985 to 2005
$2.6M
MOLECULAR CYTOGENETICS OF MULTIPLE MYELOMAR01CA080814 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI CHAGANTI, RAJU · 1999 to 2001
$538k
MOLECULAR CYTOGENETIC OF DIFFUSE LARGE CELL LYMPHOMAR01CA066999 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI CHAGANTI, RAJU · 1996 to 2000
$320k
NCI NIH HHS CA-34775NCI NIH HHS CA-66999NCI NIH HHS CA-80814
6 · The paper itself

Abstract

We report here the molecular cloning and characterization of a t(1;14)(q21;q32) in a follicular lymphoma (FL) with an unusual BCL2 aberration. Fluorescence in situ hybridization (FISH) and Southern blot analysis of tumor cells identified the translocation breakpoint within the 5' switch region of IGHG (Sgamma). We cloned the chimeric breakpoint region approximately 1.5 kbp downstream from the HindIII site of 5'Sgamma2 on chromosome 14q32 and identified a 360-bp novel segment with homology to the CpG island clone 11h8. Two BAC clones containing this sequence were isolated and mapped to 1q21 by FISH. BAC 342/P13 contained sequences homologous to Fcgamma receptors 2A, 3A, 2B, 3B, and a heat shock protein gene HSP70B. The translocation brought the Sgamma2 region of a productive IGH allele 20 approximately 30 kbp upstream of FCGR2B. As a result of the translocation, the b2 isoform of FCGR2B was overexpressed in the tumor. Screening of a panel of 76 B-cell lymphomas with 1q21-23 cytogenetic aberrations by Southern blot analysis using breakpoint probes identified an additional FL with a t(14;18)(q32;q21) and a breakpoint in the FCGR2B region. These results suggest that FCGR2B may be deregulated by 1q21 aberration in BCL2 rearranged FLs and possibly play a role in their progression.

Indexed as

Chromosomes, Human, Pair 1Chromosomes, Human, Pair 14Gene Expression RegulationTranslocation, GeneticAdultAntigens, CDBlotting, SouthernChromosome AberrationsCloning, MolecularFemaleGene RearrangementHumansIn Situ Hybridization, FluorescenceLymphoma, FollicularLymphoma, Non-HodgkinMutagenesis, InsertionalAntigens, CDFc gamma receptor IIBProto-Oncogene Proteins c-bcl-2Receptors, IgG

Identifiers

PMID11753646
OpenAlexW2313523108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.